ClinicalTrials.Veeva

Menu

Intraoperative Identification and Stimulation of the Glossopharyngeal Nerve

Vanderbilt University Medical Center logo

Vanderbilt University Medical Center

Status

Withdrawn

Conditions

Head and Neck Cancer
Obstructive Sleep Apnea

Treatments

Device: Nerve stimulation using nerve stimulation device and sterile wire electrode.

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Published data suggest that the glossopharyngeal nerve innervates pharyngeal musculature important for maintenance of upper airway patency. The investigators propose a study examining the anatomic variation of the glossopharyngeal nerve and the effect of electrical stimulation on muscle recruitment and upper airway patency.

Full description

This is a single-arm physiology study. Consenting patients undergoing parapharyngeal space (PPS) surgery for tumor extirpation will undergo dissection of the glossopharyngeal nerve branches to the stylopharyngeus and pharyngeal constrictor muscles. Fine-wire electrodes will be placed on these nerve branches. For each patient, if the target nerve branches can be identified and electrodes successfully placed, they will additionally undergo drug-induced sleep endoscopy (DISE) immediately following PPS surgery.

Per routine care, an incision is made across the neck to provide surgeons access to parapharyngeal space for tumor extirpation. During this dissection, the branch(es) of the glossopharyngeal nerve innervating the stylopharyngeus (SP) and pharyngeal constrictor (PC) muscles are exposed. For this study, measurements and photos/videos of the nerve will be taken. A fine-wire electrode will be placed on either or both successfully identified nerves and stimulated to assess muscle activation and changes in upper airway patency.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Consenting adults with BMI ≥ 25 and ≤ 40 kg/m2
  • Planned resection of parapharyngeal space (PPS) mass without clinical evidence of cranial nerve function deficits based on physical examination
  • History of moderate-to-severe Obstructive Sleep Apnea (OSA) as confirmed by previous polysomnogram OR high risk for OSA based on STOP-BANG criteria (STOP-BANG score ≥ 3)

Exclusion criteria

  • Unable to consent for research due to a pre-existing neurologic condition or language barriers as determined by PI
  • History of other primary sleep-related breathing disorder (e.g., central, or complex sleep apnea).
  • Previous pharyngeal surgery excluding tonsillectomy (e.g. cleft palate repair, uvulopalatopharyngoplasty)
  • Prior history of head and/or neck chemoradiation therapy
  • Existing indwelling neurostimulation device (e.g. pacemaker; spinal, vagal, or hypoglossal nerve stimulator)

Trial design

Primary purpose

Basic Science

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

0 participants in 1 patient group

Surgical Procedure
Other group
Description:
Consented patients who meet eligibility will have a surgical procedure for management of head and neck cancer, with dissection and exposure of the relevant anatomic structures as part of regular clinical care.
Treatment:
Device: Nerve stimulation using nerve stimulation device and sterile wire electrode.

Trial contacts and locations

1

Loading...

Central trial contact

Kate Von Wahlde

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems